The article offers the author's view on the compound of the cannabis plant, cannabidiol (CBD) and its use in Great Britain. He mentions its potential in treating schizophrenia despite the negative effect of the herbal plant on mental health. An overview of the psychoactive compound tetrahydrocannabinol (THC) and their biosynthesis controlled by allelic genes is also presented.